Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica

Vaccine

Volumn 27, Issue 39, 2009, Pages 5363-5370

  Branger, Christine G ^a   Torres Escobar, Ascención ^a   Sun, Wei ^a   Perry, Robert ^b   Fetherston, Jacqueline ^b   Roland, Kenneth L ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

LcrV; Recombinant attenuated Salmonella vaccine; Yersinia

Indexed keywords

BACTERIAL ANTIGEN; LCRV196 ANTIGEN; LIVE VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA ENTERICA TYPHIMURIUM; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS; YERSINIA TUBERCULOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CROSS REACTIONS; DNA, BACTERIAL; FEMALE; MICE; PORE FORMING CYTOTOXIC PROTEINS; SALMONELLA TYPHIMURIUM; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 68349096228     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.078     Document Type: Article

References (50)

1. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10 January (1) (1997) 35-66
2. Bottone E.J. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 10 April (2) (1997) 257-276
3. Bottone E.J. Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect 1 April (4) (1999) 323-333
4. Slee K.J., and Button C. Enteritis in sheep, goats and pigs due to Yersinia pseudotuberculosis infection. Aust Vet J 67 September (9) (1990) 320-322
5. Fukushima H., and Gomyoda M. Intestinal carriage of Yersinia pseudotuberculosis by wild birds and mammals in Japan. Appl Environ Microbiol 57 April (4) (1991) 1152-1155
6. Carniel E., and Mollaret H.H. Yersiniosis. Comp Immunol Microbiol Infect Dis 13 2 (1990) 51-58
7. Wren B.W. The Yersiniae-a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol 1 1 (2003) 55-64
8. Simonet M., and Falkow S. Invasin expression in Yersinia pseudotuberculosis. Infect Immun 60 October (10) (1992) 4414-4417
9. Grutzkau A., Hanski C., Hahn H., and Riecken E.O. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31 September (9) (1990) 1011-1015
10. Chain P.S., Carniel E., Larimer F.W., Lamerdin J., Stoutland P.O., Regala W.M., et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 101 September (38) (2004) 13826-13831
11. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413 October (6855) (2001) 523-527
12. Thomson N.R., Howard S., Wren B.W., Holden M.T., Crossman L., Challis G.L., et al. The complete genome sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica strain 8081. PLoS Genet 2 December (12) (2006) e206
13. Wauters G., Kandolo K., and Janssens M. Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol 9 (1987) 14-21
14. Heise T., and Dersch P. Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc Natl Acad Sci U S A 103 February (9) (2006) 3375-3380
15. Hudson K.J., and Bouton A.H. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection. Infect Immun 74 November (11) (2006) 6487-6490
16. Rosqvist R., Skurnik M., and Wolf-Watz H. Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature 334 August (6182) (1988) 522-524
17. Sarker M.R., Neyt C., Stainier I., and Cornelis G.R. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol 180 March (5) (1998) 1207-1214
18. Titball R.W., and Williamson E.D. Vaccination against bubonic and pneumonic plague. Vaccine 19 July (30) (2001) 4175-4184
19. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., and Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 65 February (2) (1997) 446-451
20. Sing A., Reithmeier-Rost D., Granfors K., Hill J., Roggenkamp A., and Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci U S A 102 November (44) (2005) 16049-16054
21. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 71 July (7) (2003) 3673-3681
22. Reithmeier-Rost D., Bierschenk S., Filippova N., Schroder-Braunstein J., and Sing A. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cell Immunol 231 September-October (1-2) (2004) 63-74
23. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196 October (8) (2002) 1017-1024
24. Sing A., Roggenkamp A., Geiger A.M., and Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 168 February (3) (2002) 1315-1321
25. Reithmeier-Rost D., Hill J., Elvin S.J., Williamson D., Dittmann S., Schmid A., et al. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microbes Infect 9 July (8) (2007) 997-1002
26. Pouliot K., Pan N., Wang S., Lu S., Lien E., and Goguen J.D. Evaluation of the role of LcrV-toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun 75 July (7) (2007) 3571-3580
27. Auerbuch V., and Isberg R.R. Growth of Yersinia pseudotuberculosis in mice occurs independently of toll-like receptor 2 expression and induction of interleukin-10. Infect Immun 75 July (7) (2007) 3561-3570
28. Nakajima R., and Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 61 January (1) (1993) 23-31
29. Germanier R., and Fürer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131 May (5) (1975) 553-558
30. Germanier R., and Fürer E. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect Immun 4 December (6) (1971) 663-673
31. Galan J.E., Nakayama K., and Curtiss III R. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94 September (1) (1990) 29-35
32. + expression-cloning vector: stable maintenance and high level expression of cloned gene in a Salmonella vaccine strain. Biotechnology 6 (1988) 693-697
33. Kang H.Y., and Curtiss III R. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol 37 July (2-3) (2003) 99-104
34. Kang H.Y., Srinivasan J., and Curtiss III R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 70 April (4) (2002) 1739-1749
35. Xin W., Wanda S.Y., Li Y., Wang S., Mo H., and Curtiss III R. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun 76 July (7) (2008) 3241-3254
36. Zekarias B., Mo H., and Curtiss III R. Recombinant attenuated Salmonella enterica serovar Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin Vaccine Immunol 15 May (5) (2008) 805-816
37. Koshland D., and Botstein D. Secretion of beta-lactamase requires the carboxy end of the protein. Cell 20 July (3) (1980) 749-760
38. Branger C.G., Fetherston J.D., Perry R.D., and Curtiss III R. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol 603 (2007) 387-399
39. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62 September (3) (1951) 293-300
40. Grosjean H., and Fiers W. Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene 18 June (3) (1982) 199-209
41. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 August (5259) (1970) 680-685
42. Curtiss III R., Charamella L.J., Berg C.M., and Harris P.E. Kinetic and genetic analyses of d-cycloserine inhibition and resistance in Escherichia coli. J Bacteriol 90 November (5) (1965) 1238-1250
43. Fields K.A., Nilles M.L., Cowan C., and Straley S.C. Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun 67 October (10) (1999) 5395-5408
44. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62 October (10) (1994) 4192-4201
45. Schmidt A., Schaffelhofer S., Muller K., Rollinghoff M., and Beuscher H.U. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity. Microb Pathog 26 April (4) (1999) 221-233
46. Daniel C., Sebbane F., Poiret S., Goudercourt D., Dewulf J., Mullet C., et al. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine January (7) (2009)
47. Hill J., Leary S.E., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65 November (11) (1997) 4476-4482
48. Overheim K.A., Depaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 73 August (8) (2005) 5152-5159
49. Abramov V.M., Khlebnikov V.S., Vasiliev A.M., Kosarev I.V., Vasilenko R.N., Kulikova N.L., et al. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. J Proteome Res 6 June (6) (2007) 2222-2231
50. Maier R.J., Olczak A., Maier S., Soni S., and Gunn J. Respiratory hydrogen use by Salmonella enterica serovar Typhimurium is essential for virulence. Infect Immun 72 November (11) (2004) 6294-6299